Intercept Pharmaceuticals Stock Forecast

Stock Price Forecast

The 10 analysts with 12-month price forecasts for Intercept Pharmaceuticals stock had an average target of $22.5, with a low estimate of $14 and a high estimate of $54.

Price Target: $22.5 (+18.42%)

Analyst Consensus: Hold

Price Target

Target	Low	Average	Median	High
Price	$14	$22.5	n/a	$54
Change	-26.32%	+18.42%	n/a	+184.21%

Analyst Ratings

The average analyst rating for Intercept Pharmaceuticals stock from 10 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.

Recommendation Trends

No data available

Rating	Oct 2026
Strong Buy	n/a
Buy	n/a
Hold	n/a
Sell	n/a
Strong Sell	n/a
Total	n/a

Financial Forecast

Revenue This Year

337.77M

from 285.71M

18.22%

from 285.71M

Revenue Next Year

368.48M

from 337.77M

9.09%

from 337.77M

EPS This Year

-1.33

from 6.56

EPS Next Year

2.09

from -1.33

Year	2018	2019	2020	2021	2022	2023	2024
Revenue	179.80M	252.00M	233.97M	260.75M	285.71M	337.77M	368.48M
Revenue Growth	37.30%	40.15%	-7.16%	11.45%	9.57%	18.22%	9.09%
EPS	-10.86	-10.89	-8.34	-2.87	6.56	-1.33	2.09
Forward PE	-	-	-	-	-	-	9.11
No. Analysts	-	-	-	-	-	17	17

Revenue Forecast

Revenue	2023	2024
High	354.5M	457.8M
Avg	337.8M	368.5M
Low	318.5M	304.3M

Revenue Growth

Revenue Growth	2023	2024
High	24.1%	35.5%
Avg	18.2%	9.1%
Low	11.5%	-9.9%

EPS Forecast

EPS	2023	2024
High	-0.56	3.02
Avg	-1.33	2.09
Low	-3.22	0.74

EPS Growth

EPS Growth	2023	2024
High	-	-
Avg	-	-
Low	-	-